Steel Partners has offered $18.00 per share to acquire a majority stake in InMode. ・The investment firm said the proposal ...

"The big question is whether InMode will remain in Israel," says company founder and CEO Moshe Mizrahy, talking to "Globes". The background is a control battle over the Israeli aesthetic medicine ...

Steel Partners proposes a $18 per share offer for a majority stake in InMode, citing weak returns, excess cash, and repeated ...

InMode is rumored to be in advanced deal talks with a foreign investment fund, Calcalist, an Israeli newspaper reported this week. According to the report, the medical aesthetic device company could ...

Inmode ( INMD) rose 7.5% in after-hours trading on a report that Steel Partners Holdings made an offer to buy a majority ...

Steel Partners Holdings L.P. (together with its affiliates, "Steel"), which beneficially owns approximately 1.3% of the outstanding shares of InMode Ltd. (Nasdaq: INMD) ("InMode" or the "Company"), ...

InMode’s products are part of the medical aesthetics industry that is expected to grow at an 11% CAGR over the next five years. Despite a punishing macro environment of late that has seen its share ...

It is hard to get excited after looking at InMode's (NASDAQ:INMD) recent performance, when its stock has declined ...

A foreign investment fund could scoop up medical aesthetics outlet InMode for $1.1 billion, an analyst said Monday as InMode ...

Wall Street expects a year-over-year increase in earnings on higher revenues when InMode (INMD) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important ...